prednisone has been researched along with fluconazole in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (10.53) | 18.2507 |
2000's | 18 (47.37) | 29.6817 |
2010's | 14 (36.84) | 24.3611 |
2020's | 2 (5.26) | 2.80 |
Authors | Studies |
---|---|
Duffy, EM; Jorgensen, WL | 1 |
Topliss, JG; Yoshida, F | 1 |
Abraham, MH; Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Greene, JN; Kerschner, JE; Ridley, MB | 1 |
Chaisson, RE; Moore, RD; Oursler, KA | 1 |
Hayden, ML; Jackson, S; Platts-Mills, TA; Ward, GW; Woodfolk, JA | 1 |
Breidert, M; Ehninger, G; Helwig, A; Kittner, T; Schimmelpfennig, C | 1 |
Katz, JD; Ross, JJ | 1 |
Anhalt, G; Barrett, T; Tran, M; Vonderheid, EC; Yoo, SS | 1 |
Estev, D; Jiménez-Alonso, J; Sabio, JM; Vera, C | 1 |
Barrett, T; Viglione, M; Yoo, SS | 1 |
Allaart, CF; Arend, SM; Kuijper, EJ; Muller, WH; Van Dissel, JT | 1 |
Archer, J; Lane, M; McBride, J | 1 |
Barisone, E; Bertorello, N; Corrias, A; Einaudi, S; Farinasso, L; Masera, N; Pastore, G; Riva, F; Rizzari, C; Saracco, P; Villa, A | 1 |
Betbeze, C; Tofflemire, K | 1 |
Billings, SD; Hoschar, AP; McDonnell, JK; Rushing, EC | 1 |
Andreu, M; Colom, MF; Juan-Sallés, C; Morera, N; Sánchez, M; Torres, JM; Zamora, MÁ | 1 |
Beam, E; Mansfield, AS; Thompson, CA | 1 |
Behan, JW; Declerck, B; Kim, GH; Rodriguez, PG; Zhu, TH | 1 |
Gemke, RJ; Kaspers, GJ; Rensen, N; Rotteveel, J; van Dalen, EC | 1 |
Gottlieb, T; Swan, CD | 1 |
Bordin-Wosk, T; Chun, V; Dhamija, A; Kadakia, A; Lin, AY | 1 |
She, J; Yang, L; Zhou, B; Zhu, B | 1 |
Jeng, A; Kalinoski, T; Malenfant, J; Yim, C | 1 |
5 review(s) available for prednisone and fluconazole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cryptococcal meningitis and sarcoidosis.
Topics: Adult; Brain; Cryptococcus neoformans; Female; Fluconazole; Humans; Meningitis, Cryptococcal; Prednisone; Sarcoidosis; Treatment Outcome | 2002 |
Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Topics: Adrenal Insufficiency; Antineoplastic Agents, Hormonal; Child; Cohort Studies; Dexamethasone; Fluconazole; Glucocorticoids; Humans; Hypothalamo-Hypophyseal System; Observational Studies as Topic; Pituitary-Adrenal System; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Randomized Controlled Trials as Topic | 2017 |
Topics: Adenine; Aged; Amphotericin B; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cryptococcosis; Cryptococcus neoformans; Cyclophosphamide; Doxorubicin; Empyema, Pleural; Fluconazole; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Rituximab; Vincristine | 2018 |
Coexistent pulmonary cryptococcal infection and pulmonary sarcoidosis: a case report and literature review.
Topics: Adult; Biopsy; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Humans; Lung; Lung Diseases, Fungal; Male; Prednisone; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed | 2020 |
2 trial(s) available for prednisone and fluconazole
Article | Year |
---|---|
Treatment of late-onset asthma with fluconazole.
Topics: Adult; Aged; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Antifungal Agents; Asthma; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; Histamine; Humans; Male; Middle Aged; Prednisone; Time Factors; Tinea; Treatment Outcome; Trichophyton | 1999 |
Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
Topics: Adrenal Cortex; Adrenal Insufficiency; Adrenocorticotropic Hormone; Antineoplastic Combined Chemotherapy Protocols; Child; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluconazole; Humans; Hydrocortisone; Male; Pituitary-Adrenal System; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Stress, Physiological; Substance Withdrawal Syndrome | 2008 |
31 other study(ies) available for prednisone and fluconazole
Article | Year |
---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogPoct: a tool for lipophilicity determination in drug discovery.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Solvents | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Laryngeal cryptococcus. Treatment with oral fluconazole.
Topics: Administration, Oral; Antifungal Agents; Cryptococcosis; Diabetes Mellitus, Type 1; Fluconazole; Humans; Laryngeal Diseases; Lung Diseases, Obstructive; Male; Middle Aged; Prednisone | 1995 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Risk factors for cryptococcal meningitis in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Case-Control Studies; Cerebrospinal Fluid; Cohort Studies; Female; Fluconazole; Glucocorticoids; Humans; Male; Meningitis, Cryptococcal; Prednisone; Risk Factors; Survival Analysis; Urban Population | 1999 |
Diabetes insipidus in a patient with a highly malignant B-cell lymphoma and stomatitis.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candidiasis, Oral; Cyclophosphamide; Diabetes Insipidus; Diagnosis, Differential; Doxorubicin; Esophagitis; Fluconazole; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Pituitary Gland, Posterior; Pituitary Neoplasms; Polyuria; Prednisone; Stomatitis; Thirst; Vincristine | 2000 |
Disseminated cellulitic cryptococcosis in the setting of prednisone monotherapy for pemphigus vulgaris.
Topics: Antifungal Agents; Cellulitis; Cryptococcosis; Diabetes Mellitus, Type 2; Diagnosis, Differential; Drug Administration Schedule; Fluconazole; Humans; Immunocompromised Host; Leg Ulcer; Male; Middle Aged; Pemphigus; Prednisone | 2003 |
Dysphagia in patients with systemic lupus erythematosus.
Topics: Candida albicans; Candidiasis; Deglutition Disorders; Esophagitis; Esophagoscopy; Female; Fluconazole; Follow-Up Studies; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prednisone; Risk Assessment; Treatment Outcome | 2003 |
Images in pathology: birefringent cryptococcus.
Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Birefringence; Cellulitis; Cryptococcosis; Cryptococcus; Fluconazole; Humans; Male; Middle Aged; Pemphigus; Prednisone; Skin | 2003 |
Cavitating pneumonia after treatment with infliximab and prednisone.
Topics: Antibodies, Monoclonal; Arthritis, Rheumatoid; Cryptococcosis; Female; Fluconazole; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Middle Aged; Pneumonia; Prednisone; Radiography, Thoracic; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis.
Topics: Acetazolamide; Adult; Amphotericin B; Antifungal Agents; Arachnoiditis; Cerebral Infarction; Dexamethasone; Disease Progression; Drug Therapy, Combination; Fluconazole; Flucytosine; Headache; Humans; Hydrocephalus; Immunocompetence; Male; Meningitis, Cryptococcal; Prednisone; Ventriculoperitoneal Shunt | 2004 |
Three cases of feline ocular coccidioidomycosis: presentation, clinical features, diagnosis, and treatment.
Topics: Animals; Anti-Inflammatory Agents; Antifungal Agents; Cat Diseases; Cats; Coccidioidomycosis; Eye Diseases; Female; Fluconazole; Male; Prednisolone; Prednisone | 2010 |
Iatrogenic oral hairy leukoplakia: report of two cases.
Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Clobetasol; Dapsone; Dermatologic Agents; Dexamethasone; Diabetes Mellitus, Type 2; Epstein-Barr Virus Infections; Female; Fluconazole; Humans; Immunocompromised Host; Leukoplakia, Hairy; Lichen Planus; Methotrexate; Nystatin; Prednisone; Zinc Oxide | 2011 |
Cryptococcus gattii infection in a Spanish pet ferret (Mustela putorius furo) and asymptomatic carriage in ferrets and humans from its environment.
Topics: Amplified Fragment Length Polymorphism Analysis; Animals; Anti-Inflammatory Agents; Antifungal Agents; Biopsy; Blindness; Carrier State; Cryptococcosis; Cryptococcus gattii; Ferrets; Fluconazole; Humans; Lymphatic Diseases; Meningitis, Cryptococcal; Molecular Typing; Mycological Typing Techniques; Pets; Prednisone | 2011 |
68-year-old man with neutropenic fever and upper extremity hematoma.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Candidiasis; Cyclophosphamide; Doxorubicin; Fever; Fluconazole; Hematoma; Humans; Immunocompromised Host; Infusions, Intravenous; Liver; Liver Diseases; Lymphoma, Large B-Cell, Diffuse; Male; Neutropenia; Prednisone; Rituximab; Splenic Diseases; Upper Extremity; Vincristine | 2012 |
Cryptococcal cellulitis on the shin of an immunosuppressed patient.
Topics: Amphotericin B; Antifungal Agents; Cellulitis; Cryptococcosis; Cryptococcus neoformans; Cyclosporine; Fluconazole; Flucytosine; Fungemia; Glomerulosclerosis, Focal Segmental; Humans; Immunocompromised Host; Immunosuppressive Agents; Leg Dermatoses; Male; Middle Aged; Prednisone; Skin | 2016 |
Immune reconstitution inflammatory syndrome in an HIV-infected patient with disseminated coccidioidomycosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Coccidioidomycosis; Fluconazole; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Prednisone; Treatment Outcome; Triazoles | 2019 |
Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Anti-Inflammatory Agents; Anti-Retroviral Agents; Antifungal Agents; Arachnoid; Arachnoiditis; Biopsy; Brain; Brain Abscess; Brain Edema; Cerebellar Diseases; Empyema, Subdural; Fluconazole; Flucytosine; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Prednisone; Recurrence | 2020 |